Literature DB >> 27707760

Small-cell neuroendocrine cancer of the prostate: an atypical presentation of a common disease.

Daniela Alves1, Maria Eufémia Calmeiro1, Rosa Silva1, Hugo Coelho2.   

Abstract

A 70-year-old man with a history of prostate cancer, previously submitted to surgical castration and trans-urethral resection of the prostate, was admitted to Accident and Emergency department. He had been suffering from osteoarticular and abdominal pain, and recent weight loss. An abdominal and a pelvic CT showed multiple hepatic metastases and a pelvic mass, but his prostate-specific antigen values were low (0.26 n/mL). A biopsy of a hepatic metastasis and of the pelvic mass revealed a small-cell neuroendocrine prostate cancer, a rare and aggressive androgen-independent form of prostate cancer with a poor prognosis. Our purpose was to report a clinical case of a rare and aggressive variant of a common disease. A high index of suspicion is required to make an early diagnosis and to ensure a proper therapeutic approach. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27707760      PMCID: PMC5073671          DOI: 10.1136/bcr-2016-216199

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Small cell carcinoma of the prostate: implications for management.

Authors:  F Adshead; A De Graeff; J L Mansi; D M Thomas; I E Smith
Journal:  Br J Urol       Date:  1991-02

2.  Treatment outcomes of small cell carcinoma of the prostate: a single-center study.

Authors:  Philippe E Spiess; Curtis A Pettaway; Funda Vakar-Lopez; Wassim Kassouf; Xuemei Wang; Joseph E Busby; Kim-Anh Do; Rajayogesh Davuluri; Nizar M Tannir
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

3.  Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review.

Authors:  Masahiro Yashi; Fumihito Terauchi; Akinori Nukui; Masanori Ochi; Masayuki Yuzawa; Yosuke Hara; Tatsuo Morita
Journal:  Urol Oncol       Date:  2006 Jul-Aug       Impact factor: 3.498

Review 4.  Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities.

Authors:  Nadezda Vashchenko; Per-Anders Abrahamsson
Journal:  Eur Urol       Date:  2005-02       Impact factor: 20.096

Review 5.  Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.

Authors:  Cristian I Surcel; Inge M van Oort; Prasanna Sooriakumaran; Alberto Briganti; Peter J L De Visschere; Jurgen J Fütterer; Pirus Ghadjar; Hendrik Isbarn; Piet Ost; Roderick C N van den Bergh; Ofer Yossepowitch; Gianluca Giannarini; Guillaume Ploussard
Journal:  Urol Oncol       Date:  2014-09-17       Impact factor: 3.498

6.  Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment.

Authors:  G Ahlgren; K Pedersen; S Lundberg; G Aus; J Hugosson; P A Abrahamsson
Journal:  Prostate       Date:  2000-03-01       Impact factor: 4.104

7.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

8.  Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia.

Authors:  R E Wenk; B S Bhagavan; R Levy; D Miller; W Weisburger
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

Review 9.  Neuroendocrine lesions of the genitourinary tract.

Authors:  Samson W Fine
Journal:  Adv Anat Pathol       Date:  2007-07       Impact factor: 3.875

10.  Review of small cell carcinomas of the prostate.

Authors:  P Furtado; M V A Lima; C Nogueira; M Franco; F Tavora
Journal:  Prostate Cancer       Date:  2011-08-04
View more
  5 in total

1.  A Case Report on Atypical Presentation of Metastatic Prostate Cancer.

Authors:  Anthony Lyonga Ngonge; Stacy N Amadife; Felix W Wireko; Isaac Ikwu; Vishal Poddar
Journal:  Cureus       Date:  2022-01-04

2.  Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.

Authors:  Jill B Feffer; Natalia M Branis; Jeanine B Albu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-18       Impact factor: 5.555

3.  Poorly Differentiated Small-Cell-Type Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review.

Authors:  Kishore Kumar; Rafeeq Ahmed; Chime Chukwunonso; Hassan Tariq; Masooma Niazi; Jasbir Makker; Ariyo Ihimoyan
Journal:  Case Rep Oncol       Date:  2018-10-31

4.  Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.

Authors:  Jiping Yao; Yanning Liu; Xue Liang; Jiajia Shao; Yina Zhang; Jing Yang; Min Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-08       Impact factor: 5.555

5.  Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report.

Authors:  Yonglin Zhang; Chao Liu; Chaoting Zheng; Qiaozhen Ren; Qimin Wang; Xinyi Gao; Yushuang He; Jierong Wu; Guanglei Chen; Xuelu Li; Zhenhai Ma
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.